𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCN18 LETROZOLE (FEMARA) IS A COST-EFFECTIVE TREATMENT IN THE EXTENDED ADJUVANT SETTING IN WOMEN WITH EARLY BREAST CANCER: AN APPLICATION TO CANADA

✍ Scribed by K El Ouagari; W Tal bot

Book ID: 118607526
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 64 KB
Volume: 8
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)67256-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Letrozole in the E

Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

✍ Khalid El Ouagari; Jon Karnon; Thomas Delea; Willena Talbot; Jane Brandman 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 254 KB

PCN72 COST-EFFECTIVENESS OF LETROZOLE AN

PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1–98 AND ATAC TRIALS:A UK PERSPECTIVE

✍ J Karnon; S Kaura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Anastrozole is safer and may be more eff

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10

✍ Hetty Carraway; Antonio C. Wolff 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB